PMA supplement
P030005 S162: Valitude / Valitude X4 / Visionist / Visionist X4 / Accolade Cardiac Resynchronization Therapy Pacemaker (CRT-P) Devices
FDA PMA supplement · 30-Day Notice · Guidant Corp.
Key facts
| Original PMA | P030005 |
|---|---|
| Supplement number | S162 |
| Supplement type | 30-Day Notice |
| Reason for the supplement | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | Valitude / Valitude X4 / Visionist / Visionist X4 / Accolade Cardiac Resynchronization Therapy Pacemaker (CRT-P) Devices |
| Generic name | Pulse generator, pacemaker, implantable, with cardiac resynchronization (CRT-P) |
| Applicant | Guidant Corp. |
| Product code | NKE |
| Received date | Sep 27, 2017 |
| Decision date | Oct 18, 2017 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: